{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:58:38Z","timestamp":1785221918317,"version":"3.55.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This umbrella review will synthesize evidence on the effectiveness and safety of pharmacological treatments for autoimmune hepatitis across all age groups, including patients with refractory disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Autoimmune hepatitis is a chronic, immune-mediated liver disease that affects all ages. It is more common in women and is characterized by persistent hepatocellular inflammation and interface hepatitis, elevated transaminases, and increased immunoglobulin G and autoantibodies. Although prednisolone and\/or azathioprine is the standard treatment, over 20% of patients do not respond or tolerate this treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Eligibility criteria:<\/jats:title>\n                    <jats:p>This review will consider systematic reviews and meta-analyses that evaluate any first- or second-line pharmacological treatment for autoimmune hepatitis, administered to pediatric, adult, or older adult populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review will follow the JBI methodology for umbrella reviews. Searches will be conducted in CINAHL (EBSCOhost), Cochrane Library, Embase (Ovid), LILACS, PubMed, and Scopus. Title\/abstract, full-text screening, and data extraction will be performed independently by 2 reviewers, with a predefined procedure in place to resolve disagreements. The quality of the systematic reviews will be appraised using the JBI critical appraisal checklist for systematic reviews, and the certainty of the evidence will be judged using a GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach modified for umbrella reviews. The findings will be presented in tables and figures, with a narrative synthesis and primary stratification by age group and treatment response (eg, treatment-na\u00efve vs. refractory patients). Subgroup and sensitivity analyses are pre-specified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review registration:<\/jats:title>\n                    <jats:p>PROSPERO CRD420251072878.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.11124\/jbies-26-00039","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:00:24Z","timestamp":1785218424000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of treatments for autoimmune hepatitis across all age groups: an umbrella review protocol"],"prefix":"10.11124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6578-9926","authenticated-orcid":false,"given":"Ana Paula","family":"Bohn Kaspary","sequence":"first","affiliation":[{"name":"School of Nursing, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9381-8627","authenticated-orcid":false,"given":"Mayra","family":"Carvalho-Ribeiro","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-3621","authenticated-orcid":false,"given":"Fl\u00e1via Oliveira Motta","family":"Maia","sequence":"additional","affiliation":[{"name":"School of Nursing, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil"},{"name":"JBI Universidade Estadual de Campinas Evidence-Based Healthcare Research Centre, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-5387","authenticated-orcid":false,"given":"Lucieni","family":"Oliveira Conterno","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-518X","authenticated-orcid":false,"given":"Daniela Fernanda dos Santos","family":"Alves","sequence":"additional","affiliation":[{"name":"School of Nursing, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil"},{"name":"JBI Universidade Estadual de Campinas Evidence-Based Healthcare Research Centre, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"6","key":"R1-20260728","doi-asserted-by":"crossref","first-page":"2193-213","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatol"},{"issue":"1","key":"R2-20260728","doi-asserted-by":"crossref","first-page":"54-66","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"R3-20260728","doi-asserted-by":"crossref","first-page":"169-76","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatol"},{"issue":"5","key":"R4-20260728","doi-asserted-by":"crossref","first-page":"929-38","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R5-20260728","first-page":"380:e070201","article-title":"Diagnosis and management of autoimmune hepatitis","author":"Muratori","year":"2023","journal-title":"BMJ"},{"key":"R6-20260728","doi-asserted-by":"crossref","first-page":"102280","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis","volume":"65","author":"Hahn","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"2","key":"R7-20260728","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL Clinical Practice Guidelines on the management of autoimmune hepatitis","volume":"83","author":"Dalekos","year":"2025","journal-title":"J Hepatol"},{"issue":"11","key":"R8-20260728","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4254\/wjh.v13.i11.1642","article-title":"Health-related quality of life in autoimmune hepatitis","volume":"13","author":"Snijders","year":"2021","journal-title":"World J Hepatol"},{"issue":"3","key":"R9-20260728","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2013.10.035","article-title":"Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis","volume":"60","author":"Schramm","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"R10-20260728","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jped.2017.10.013","article-title":"Decreased health-related quality of life in children and adolescents with autoimmune hepatitis","volume":"95","author":"Bozzini","year":"2019","journal-title":"J Pediatr (Rio J)"},{"issue":"10","key":"R11-20260728","doi-asserted-by":"crossref","first-page":"e0204772","DOI":"10.1371\/journal.pone.0204772","article-title":"Health-related quality of life in patients with autoimmune hepatitis: a questionnaire survey","volume":"13","author":"Takahashi","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"R12-20260728","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/hep.30031","article-title":"The impact of autoimmune hepatitis and its treatment on health utility","volume":"68","author":"Wong","year":"2018","journal-title":"Hepatol"},{"issue":"6","key":"R13-20260728","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jhep.2012.09.002","article-title":"Treatment adherence - room for improvement, not only in autoimmune hepatitis","volume":"57","author":"Weiler-Normann","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"R14-20260728","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2012.07.032","article-title":"Identifying opportunities to improve management of autoimmune hepatitis: evaluation of drug adherence and psychosocial factors","volume":"57","author":"Sockalingam","year":"2012","journal-title":"J Hepatol"},{"issue":"2","key":"R15-20260728","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatol"},{"issue":"2","key":"R16-20260728","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12072-021-10170-1","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis","volume":"15","author":"Wang","year":"2021","journal-title":"Hepatol Int"},{"issue":"2","key":"R17-20260728","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MEG.0000000000001019","article-title":"A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment","volume":"30","author":"M","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3-4","key":"R18-20260728","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1751-2980.13348","article-title":"MMF is an effective and safer treatment options for treatment-naive patients with autoimmune hepatitis compared to azathioprine: a systematic review and meta-analysis","volume":"26","author":"Anwar","year":"2025","journal-title":"J Dig Dis"},{"issue":"6","key":"R19-20260728","first-page":"1155","article-title":"Calcineurin inhibitors in the treatment of adult autoimmune hepatitis: a systematic review","volume":"10","author":"Baven-Pronk","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"9","key":"R20-20260728","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/gutjnl-2024-333171","article-title":"British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis","volume":"74","author":"Gleeson","year":"2025","journal-title":"Gut"},{"issue":"22","key":"R21-20260728","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.3748\/wjg.v25.i22.2809","article-title":"Autoimmune hepatitis treatment in the elderly: a systematic review","volume":"25","author":"Durazzo","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R28-20260728","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"R29-20260728","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"}],"container-title":["JBI Evidence Synthesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.11124\/JBIES-26-00039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:00:27Z","timestamp":1785218427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.11124\/JBIES-26-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":23,"URL":"https:\/\/doi.org\/10.11124\/jbies-26-00039","relation":{},"ISSN":["2689-8381"],"issn-type":[{"value":"2689-8381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}